Physician profile
Tim Carlson
NPI 1649380478
$701.90
in general payments reported to CMS, 2019-2025
17 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.30 · 2020: $31.84 · 2022: $236 · 2023: $40.27 · 2024: $23.26 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $380.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $130.72 | 2022-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $83.71 | 2022-2025 | |
| Medtronic, INC. | $70.92 | 2022 | |
| Glaxosmithkline, LLC. | $65.08 | 2019-2025 | Trelegy Ellipta |
| Pfizer INC. | $61.10 | 2025 | |
| Amgen INC. | $41.17 | 2019-2025 | Otezla, Repatha |
| Boston Scientific Corporation | $33.02 | 2025 | Watchman Access System |
| Abbvie INC. | $32.09 | 2025 | |
| Abbott Laboratories | $28.12 | 2020-2022 | |
| Abiomed | $23.26 | 2024 | Impella |
| Astellas Pharma US INC | $22.73 | 2023 | Myrbetriq |
| Novartis Pharmaceuticals Corporation | $21.34 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.53 | 2025 | Jardiance |
| Exact Sciences Corporation | $20.16 | 2025 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $18.87 | 2025 | Nexletol |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $16.81 | 2020 | |
| Amarin Pharma, INC. | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tim Carlson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.